NCT00366652

Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects

A Randomized, Open-Label, Crossover, Drug Interaction Study to Evaluate the Effects of DVS SR And Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the effects of multiple doses of DVS SR and duloxetine on the pharmacokinetics of a single dose of desipramine in healthy subjects.

Conditions

• Depression
• Depressive Disorder
• Depressive Disorder, Major

Interventions

Type	Name	Description
DRUG	desvenlafaxine SR
DRUG	desipramine
DRUG	duloxetine

Timeline

• Start date: 2006-09-01
• Completion: 2006-09-01
• First posted: 2006-08-21
• Last updated: 2007-05-28

Locations

1 site across 1 country: United States